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background: Iron deﬁciency during pregnancy is associated with adverse birth outcomes, particularly, if present during early gestation.
Iron supplements are widely recommended during pregnancy, but evidence of their beneﬁt in relation to infant outcomes is not established.
This study was performed in the UK, where iron supplements are not routinely recommended during pregnancy, to investigate the associ-
ation between iron intake in pregnancy and size at birth.
methods: From a prospective cohort of 1274 pregnant women aged 18–45 years, dietary intake was reported in a 24-h recall adminis-
tered by a research midwife at 12-week gestation. Dietary supplement intake was ascertained using dietary recall and three questionnaires in
the ﬁrst, second and third trimesters.
results: Of the cohort of pregnant women, 80% reported dietary iron intake below the UK Reference Nutrient Intake of 14.8 mg/day.
Those reported taking iron-containing supplements in the ﬁrst, second and third trimesters were 24, 15 and 8%, respectively. Women with
dietary iron intake .14.8 mg/day were more likely to be older, have a higher socioeconomic proﬁle and take supplements during the ﬁrst
trimester. Vegetarians were less likely to have low dietary iron intake [odds ratio ¼ 0.5, 95% conﬁdence interval (CI): 0.4, 0.8] and more
likely to take supplements during the ﬁrst and second trimesters. Total iron intake, but not iron intake from food only, was associated
with birthweight centile (adjusted change ¼ 2.5 centiles/10 mg increase in iron, 95% CI: 0.4, 4.6). This association was stronger in the
high vitamin C intake group, but effect modiﬁcation was not signiﬁcant.
conclusion: There was a positive relationship between total iron intake, from food and supplements, in early pregnancy and birth-
weight. Iron intake, both from diet and supplements, during the ﬁrst trimester of pregnancy was higher in vegetarians and women with a
better socioeconomic proﬁle.
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Introduction
Iron deﬁciency during pregnancy is still common in developed
countries (Beard, 1994; Milman et al., 1998; Robinson et al., 1998;
Bergmann et al., 2002). It is associated with adverse birth outcomes
such as small for gestational age (SGA), preterm birth and delayed off-
spring neurological development, particularly if present during the ﬁrst
half of pregnancy (Zhou et al., 1998; Scholl, 2005; Rao and Georgieff,
2007; Beard, 2008; Baker et al., 2009). There is evidence from animal
studies that low iron intake during pregnancy adversely affects the off-
spring’s blood pressure, obesity levels and other cardiovascular
outcomes in the long term (Gambling et al., 2003; Lisle et al., 2003;
Gambling et al., 2004; Zhang et al., 2005; Andersen et al., 2006).
Iron supplements are widely recommended and used during preg-
nancy worldwide (Centers for Disease Control and Prevention,
1998; World Health Organization, 2006). There are far more
studies examining the effect of iron supplements during pregnancy
than those measuring total dietary iron intake in the mother and inves-
tigating its association with birth outcomes (Preziosi et al., 1997;
Christian et al., 2003; Cogswell et al., 2003; Vaidya et al., 2008).
However, the evidence on what beneﬁt iron supplements contribute
to infant outcomes is still not established (Pena-Rosas and Viteri,
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2009), and their routine use has drawbacks such as gastrointestinal
side effects and interactions with other micronutrients especially if
taken as part of a multivitamin-mineral supplement (Rossander-Hulten
et al., 1991; O’Brien et al., 1999, 2000; Roughead and Hunt, 2000).
Iron supplements can also reduce the absorption of dietary
non-heme iron (Roughead and Hunt, 2000) and can increase oxidative
stress and the production of free radicals (Casanueva and Viteri, 2003;
Scholl, 2005). Therefore, they are not routinely recommended during
pregnancy in the UK (NICE, 2008).
In the USA, a dietary iron intake of 27 mg/day during pregnancy is
recommended (IOM, 2001). In the US National Health and Nutrition
Examination Survey III, median iron intake in pregnant women was
15 mg/day (National Center for Health Statistics, 1994). In the UK,
the Reference Nutrient Intake (RNI) for women aged 19–50 years
is 14.8 mg/day, and Lower Reference Nutrient Intake (LRNI) is
8 mg/day, with no speciﬁc recommended increment during pregnancy
(Department of Health, 1991). The RNI is the amount of a nutrient
that is enough to ensure that the needs of 97.5% of the population
are being met. LRNI is the amount adequate for only the small
number of people who have low requirements (2.5%) (Department
of Health, 1991). The mean daily dietary intake of total iron from
the 2001 National Diet and Nutrition Survey in Great Britain was
10 mg for women aged 19–64 years (FSA, 2003). Around 25% of
women aged 19–64 years, 41% of women aged ,34 years and
53% of women receiving income-beneﬁts had daily dietary iron
intakes less than the LRNI. Such low levels of iron intake were also
seen in other European countries such as Denmark (Andersen
et al., 1995). There is evidence from nutritional surveys in the UK
and Norway that women’s dietary patterns change little with preg-
nancy (Trygg et al., 1995; Crozier et al., 2009). In the latter survey,
96% of pregnant women had an iron intake ,18 mg/day with an
average iron intake of 11 mg/day (Trygg et al., 1995). To meet the
iron demand in pregnancy, women would need to make considerable
changes in their dietary pattern, which some argue to be unrealistic,
hence the recommendation of iron supplements. However, it has
been shown that transfer of iron to the fetus is better in non-iron sup-
plemented than in supplemented women (O’Brien et al., 2003).
Dietary iron occurs in two forms: heme and non-heme. About 95%
of iron in the average British diet is in the form of non-heme iron
(Food Standards Agency, 2003). The extent to which non-heme
iron is absorbed is highly variable and depends on the individual’s
iron status and other dietary components. Ascorbic acid enhances
non-heme iron absorption when consumed as part of a meal
(Skikne and Baynes, 1994), while high calcium intakes during preg-
nancy might reduce non-heme iron absorption, leading to iron
deﬁciency (Robinson et al., 1998). Heme iron comes mainly from
meat. It has a higher bioavailability and is well absorbed. Its absorption
is further facilitated by organic compounds present in meat called meat
factors (Skikne and Baynes, 1994). Unlike that of the non-heme iron,
heme iron absorption is inﬂuenced little by other dietary constituents.
It also enhances non-heme iron absorption from other foods con-
sumed at the same time. Recent evidence suggests that heme and
non-heme iron may have different associations with individual health
outcomes (Tzoulaki et al., 2008).
Results of studies investigating the relationship between dietary
maternal iron intake during pregnancy and size at birth and/or gesta-
tional age are conﬂicting (Doyle et al., 1990; Haste et al., 1991; Scholl
et al., 1992; Scholl and Hediger, 1994; Godfrey et al., 1996; Mathews
et al., 1999, 2004; Mitchell et al., 2004; Lagiou et al., 2005;
Al-Shoshan, 2007; Baker et al., 2009). Many studies that have assessed
total iron intake did not model the relationships separately for iron
from food and that from dietary supplements. Neither did they con-
sider the potential differential effects of heme and non-heme iron.
One study assessed the relationship between ascorbic acid and
anemia and well as vitamin C intake and iron status (Baker et al.,
2009); however, the potential interaction between iron intake and
the vitamin C intake and other micronutrients has not been explored
(Gibney et al., 2004). The aims of this study were to investigate the
association between maternal iron intake during early pregnancy and
both birthweight and gestational age, to assess whether any relation-
ships differ by source of iron (food versus dietary supplements) or by
type of iron (heme versus non-heme), and to explore the role of
vitamin C intake as an effect modiﬁer.
Materials and Methods
Study design and participants
The Caffeine and Reproductive Health (CARE) study is a prospective birth
cohort in which low-risk pregnant women aged 18–45 years with single-
ton pregnancies were prospectively recruited at 8–12-week gestation
from the Leeds Teaching Hospitals maternity units between 2003 and
2006. This was part of a multicentre study into maternal diet and birth
outcomes. Women with concurrent medical disorders, psychiatric
illness, human immunodeﬁciency virus infection or hepatitis B infection
were excluded. Eligible women were identiﬁed by screening their pre-
booking maternity notes. They were then sent detailed information
about the study and were asked to return a reply slip to state whether
they were willing to take part. Those who agreed to participate were
then interviewed. This interview was conducted either at the hospital,
the participant’s general practice, or her home by a research midwife.
Demographic details were obtained using a self-reported questionnaire.
Information was obtained from the hospital maternity records on antenatal
pregnancy complications and delivery details (gestational age at delivery,
birthweight and sex of the baby). Data on hemoglobin (Hb) levels and
mean corpuscular volume (MCV) at 12 and 28 weeks pregnancy were
available for a subsample of the cohort that was selected randomly from
the main sample using study identiﬁcation numbers. All women participat-
ing in the study gave written informed consent, and the study was
approved by the Leeds West Local Research Ethics Committee (reference
number 03/054).
Assessment of diet and supplement use
Supplement use was ascertained throughout pregnancy using question-
naires in the ﬁrst, second and third trimesters. The questionnaires were
interviewer administered during the ﬁrst (up to 12-week gestation) and
third trimester (from 28-week gestation) and self-administered during
the second trimester (13–27-week gestation). The respondents were
asked to report the type/brand, frequency and the amount of all the
dietary supplements they were using during each trimester.
Dietary and supplement intake was reported through a 24-h dietary
recall administered by a research midwife at 8–12-week gestation.
Values for the proportion of heme iron in each type of meat were used
to derive heme values for each of the food codes. These values were
derived by recording the meat content of each product, together with
food tables values (McCance, 1990), to calculate a weighted mean meat
content of each food item consumed. A literature search was carried
912 Alwan et al.
out to arrive at ‘heme factors’ for different animal products that reﬂect the
heme iron content of these foods. Values derived from the Schricker and
modiﬁed Schricker methods, and the Hornsey method was used to calcu-
late mean values for heme iron (Hornsey, 1956; Schricker and Stouffer,
1982). These values were then used to generate total iron values for
each relevant food (O’Hara, 2004). The non-heme iron values were
derived as the difference between total iron from food tables
(McCance, 1990) and calculated heme values. Total iron was derived
from adding dietary intake and supplement intake as reported in the
recall. Iron content of each supplement reported was added to the
dietary intake multiplied by total number of supplement tablets/capsules
taken during the 24-h recall. Vitamin C intake from the diet was reported
in the 24-h recall and categorized into above or equal to/below the RNI of
50 mg/day.
Assessment of outcomes
The two primary outcome measures were birthweight and preterm birth.
Birthweight was measured in grams, and expressed as customized centile
using charts that take into account gestational age, maternal height, weight,
ethnicity and parity, and neonatal birthweight and sex (Gardosi, 2004).
Duration of gestation was calculated from the date of the last menstrual
period, and conﬁrmed by ultrasound scans dating at around 12 and
20-week gestation. SGA was deﬁned as less than the 10th centile for gesta-
tional age. Preterm birth was deﬁned as delivery at ,37-week (259 days)
gestation.
Assessment of participants’ characteristics
Socioeconomic status was assessed using the Index of Multiple Depri-
vation (IMD) score. The IMD 2007 combines a number of indicators
(chosen to cover a range of economic, social and housing issues) into a
single deprivation score for each small area in England. This allows each
area to be ranked relative to one another according to their level of depri-
vation (Department for Communities and Local Government, 2009). IMD,
however, is an area (not an individual) deprivation measure.
Mothers’ educational level, smoking status, alcohol intake, parity, ethni-
city, pre-pregnancy weight, past history of miscarriage, long-term chronic
illness and vegetarian diet were self-reported in a ﬁrst-trimester question-
naire. Salivary cotinine levels were measured using an enzyme-linked
immunosorbent assay (Cozart Bioscience, Oxfordshire, UK). Participants
were classiﬁed, on the basis of these cotinine concentrations, as active
smokers (.5 ng/ml), passive/occasional smokers (1–5 ng/ml) or non-
smokers (,1 ng/ml; CARE Study Group, 2008).
Statistical power calculations
Comparing birthweights between mothers with dietary iron intake of
.14.8 mg/day (the recommended UK RNI for women of childbearing
age) with those with ≤14.8 mg/day during the ﬁrst trimester of preg-
nancy, using the ratios of the low-intake to the high-intake group and
the standard deviation for birthweight identiﬁed in this study (SD ¼
577 g), we had 85% power to detect a difference of 120 g in birthweight
between the two groups for P, 0.05 and a two-sided test.
Statistical methods
Univariable comparisons were made using Student’s t-test for continuous
variables and x2 test for categorical variables. Multiple linear regression
using birthweight/customized birth centile as continuous outcomes, and
unconditional logistic regression with preterm birth and SGA as binary
outcomes were performed using STATA version 11 (College Station,
TX, 2009).
Analyses were conducted using dietary iron intake as a continuous
variable and a binary variable using the UK RNI cut-off of 14.8 mg/
day. Total iron from diet and supplements, assessed by the 24-h
recall, was analyzed as a continuous variable. Intake of iron-containing
supplements was analyzed as a binary variable. Maternal height,
weight, ethnicity, parity, neonatal gestation at delivery and baby’s sex
were taken into account in the deﬁnition for customized birth centile,
and were adjusted for in the model for birthweight. Statistical adjustment
was also made for maternal age, salivary cotinine levels and alcohol con-
sumption. Sensitivity analyses for the linear model were performed by
excluding vegetarians from the model, and adding an interaction term
for daily vitamin C intake in the model. Subgroup analysis using the mul-
tiple linear model was performed using type of dietary iron (heme versus
non-heme). Multiple linear regression was also used to explore the
association between iron intake and Hb and MCV levels at 12 and 28
weeks of pregnancy.
Results
Iron intake
A total of 1257 women had dietary recall information in the ﬁrst tri-
mester. The mean dietary iron intake from food was 11.5 mg/day
(SD ¼ 5.3), with only 20% (n ¼ 257) of women reporting intake
.14.8 mg/day [95% conﬁdence interval (CI): 18, 23%]. Women
who reported iron intake less than or equal to the UK LRNI of
8 mg/day were 24% (95% CI: 22%, 27%). Only 4% reported a
dietary iron intake of more than the US recommended intake during
pregnancy of 27 mg/day (95% CI: 3, 5%). Mean heme iron intake
was 0.6 mg/day (SD ¼ 0.8). This estimate for heme iron changed
little after excluding the 114 reported vegetarian participants (with a
heme iron intake of zero). Mean non-heme iron intake was
10.9 mg/day (SD ¼ 5.2; Table I).
In the recall, 20% of participants (95% CI: 18%, 22%) reported
taking iron-containing supplements compared with 24% (95% CI:
22%, 26%) in the ﬁrst trimester questionnaire (Kappa agreement ¼
0.85). 15% (95% CI: 13%, 18%) and 8% (95% CI: 7%, 10%) reported
taking iron-containing supplements in the second and third trimester
questionnaires, respectively. Mean total iron intake from diet and sup-
plements, as recorded in the recall, was 16.5 mg/day (SD ¼ 21.1).
34% (95% CI: 32%, 37%) of women had an iron intake .14.8 mg/
day from diet and supplements. Only 11 participants reported
taking iron-only preparations in the recall, which were assumed to
be the conventional therapeutic preparation with a dose of 65 mg
iron/tablet, and 5 reported taking a preparation of iron and folic
acid that contains 100 mg iron per dose. Mean total iron excluding
these 16 participants was 14.3 mg/day (SD ¼ 8.4). Only 8, 21 and
29 participants reported taking iron-only supplements in the ﬁrst,
second and third trimester questionnaires, respectively.
Characteristics of women with high versus
low iron intake groups
Women with dietary iron intake .14.8 mg/day were more likely to
be older, report a higher total energy intake (Kcal/day), have a univer-
sity degree, be vegetarian and take daily supplements during the ﬁrst
trimester, including iron-containing supplements. They were less
likely to be smokers, live in an area with the worst IMD quartile or
have a long-term illness (Table II). Vegetarian participants were less
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likely to have dietary iron intake ≤14.8 mg/day [unadjusted odds ratio
(OR) ¼ 0.5, 95% CI: 0.4, 0.8, P ¼ 0.004]. Vegetarians were also more
likely to take iron-containing supplements during the ﬁrst and second
trimester (OR ¼ 2.9, 95% CI: 2.0, 4.3, P, 0.0001 for the ﬁrst trime-
ster; OR ¼ 2.9, 95% CI: 1.9, 4.4, P, 0.0001 for the second
trimester).
Birth outcomes
There were 1259 babies with information on birthweight. Mean birth-
weight was 3439 g (SD ¼ 577 g) with 4.4% of babies weighing
,2500 g (n ¼ 55). Totally, 13% (n ¼ 166) weighed less than the
10th centile, 8% (n ¼ 99) less than the ﬁfth centile and 5% (n ¼ 65)
less than the third centile. Babies weighing more than the 90th
centile were 9% (n ¼ 118). Of the 1234 pregnancies with information
on gestational age, 55 (4.5%) delivered before 37-week gestation.
Relationship between blood indices and birth
outcome
The number of participants who had information on Hb and MCV at
12 and 28-week gestation were 558 and 572, respectively. Mean Hb
was 12.7 g/dl (SD ¼ 0.9 g/dl) at 12 weeks and 11.5 g/dl (SD ¼
1 g/dl) at 28 weeks. The proportion of participants with Hb
,11 g/dl was 3% at 12 weeks and 23% at 28 weeks. Mean MCV
was 90 ﬂ (SD ¼ 5.0 ﬂ) at 12 weeks and 89 ﬂ (SD ¼ 5.5 ﬂ) at 28
weeks. There was no relationship between customized birth centile
or birthweight in grams and Hb/MCV at 12 or 28-week pregnancy
in this study. Hb at 28 weeks was associated with SGA (unadjusted
OR per g/dl increase in Hb ¼ 1.4, 95% CI: 1.1, 1.8, P ¼ 0.02; OR
adjusted for maternal age, salivary cotinine levels and alcohol
intake ¼ 1.4, 95% CI: 1, 1.8, P ¼ 0.03). Adjusting for dietary iron
intake did not alter this relationship.
Relationship between blood indices
and dietary intake
There was no relationship between Hb/MCV at 12 or 28-week preg-
nancy with dietary iron intake in the ﬁrst trimester. However, there
was a positive relationship between taking iron-containing sup-
plements as reported in the ﬁrst trimester questionnaire and Hb at
12 and 28 weeks, and MCV at 28 weeks. The relationship remained
signiﬁcant for Hb at 12 and 28 weeks after adjusting for maternal
age, ethnicity, parity, educational attainment, vegetarian diet and
IMD score in multiple linear regression model. Taking iron-containing
supplements in the second trimester was also positively associated
with Hb at 28 weeks (Table III).
Relationship between iron intake
and birthweight
Dietary iron intake from food was signiﬁcantly related to birthweight
measured on the customized birth centile (unadjusted change per
10 mg/day increase in dietary iron intake during the ﬁrst trimester ¼
5.2 centile points, 95% CI: 2.2, 8.2, P ¼ 0.001). Adjusting for maternal
age, salivary cotinine levels and alcohol intake attenuated this relation-
ship (adjusted change ¼ 3.1 centile points, 95% CI: 20.2, 6.3, P ¼
0.07; Table IV). The estimate changed little when excluding veg-
etarians, or including calcium or zinc intake as interaction terms with
iron intake (data not shown). Considering birthweight in grams as
an outcome, the unadjusted change per 10 mg/day increase in
dietary iron intake was 70 g (95% CI: 10, 130, P ¼ 0.02). When adjust-
ing for maternal age, cotinine levels, alcohol intake, maternal weight,
height, parity, ethnicity, gestational age and baby’s sex, the change
was 34 g (95% CI: 213, 80, P ¼ 0.2).
There was no relationship between heme iron intake and custo-
mized birth centile (unadjusted change per 1 mg/day increase in
heme iron intake ¼ 21.2 centile points, 95% CI: 23.3, 0.8,
P ¼ 0.2), while the relationship was statistically signiﬁcant for
non-heme iron (unadjusted change per 1 mg/day increase in
non-heme iron intake ¼ 0.6, 95% CI: 0.3, 0.9, P, 0.0001; adjusted
change ¼ 0.3, 95% CI: 0, 0.9, P ¼ 0.05). There was a positive relation-
ship between total iron intake, from food and supplements, with cus-
tomized birth centile (unadjusted change per 10 mg/day increase in
total iron intake ¼ 4.3, 95% CI: 2.4, 6.3, P, 0.0001, adjusted
change ¼ 2.5, 95% CI 0.4, 4.6, P ¼ 0.02; Table IV).
Role of vitamin C intake
The relationship between dietary iron intake from food and custo-
mized birth centile was signiﬁcant in participants with vitamin C
intake above 50 mg/day (adjusted change per 10 mg/day increase in
dietary iron intake ¼ 3.9, 95% CI: 0.4, 7.5, P ¼ 0.03), compared
with 21.9 (95% CI: 211.1, 7.5, P ¼ 0.7, n ¼ 253) for those with
vitamin C intake ≤50 mg/day. However, the interaction between
iron and vitamin C intakes on the outcome was not signiﬁcant
(P ¼ 0.3). Similar relationships were observed for non-heme iron
.............................................................................................................................................................................................
Table I Average iron intake from food and dietary supplements as reported in ﬁrst trimester 24-h dietary recall
(n5 1257).
Mean Standard
deviation
Median Inter-quartile
range
Iron intake from food (mg/day) 11.5 5.3 10.5 8.1, 13.7
Heme iron intake (mg/day) 0.6 0.8 0.3 0.1, 0.8
Non-heme iron intake (mg/day) 10.9 5.2 10 7.6, 13.0
Total iron from food and supplements (mg/day) 16.5 21.1 11.8 8.6, 19.1
Total iron from food and supplements excluding therapeutic iron preparations
(≥65 mg/dose) (mg/day)
14.3 8.4 11.6 8.5, 18.6
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and total iron intake from diet and supplements using an interaction
term between iron intake and vitamin C intake in the models
(Table IV).
Relationship between iron intake and small
for gestational age
Participants with dietary iron intake ≤14.8 mg/day were 1.6 times
more likely to have a SGA baby (95% CI: 1.0, 2.5, P ¼ 0.05).
However, the adjusted relationship was not signiﬁcant (1.4, 95% CI:
0.9, 2.3, P ¼ 0.2). This pattern is similar for total iron intake from
diet and supplements (Table IV).
Relationship between iron intake
and preterm birth
There was no relationship between iron intake from diet only, or from
diet and supplements, as recorded in the recall diary in the ﬁrst trime-
ster, and preterm birth (Table IV).
Relationship between intake of
iron-containing supplements and birth
outcomes
There was no association between daily intake of iron-containing
supplements in the ﬁrst and second trimester and customized
birth centile. There was an inverse association between taking
iron-containing supplements in the third trimester (73% of which as
part of multivitamin-mineral preparations) and customized birth
centile adjusted for salivary cotinine levels, alcohol intake and maternal
age (adjusted difference¼ 210.7, 95% CI: 216.7, 24.8, P, 0.0001).
Discussion
This study shows a positive relationship between both total iron intake
(from food and supplements) and non-heme iron intake, derived from
24-h dietary recall in the ﬁrst trimester of pregnancy, and birthweight.
There was no association between iron intake and preterm birth.
Strengths and limitations of the study
This was a large prospective cohort study. Although a randomized
controlled trial is the gold standard study design to investigate causal-
ity, this design would be difﬁcult to execute especially when the
exposure is dietary intake. The response rate to take part in the
study was 20% out of all the women who were invited, and the per-
centage of low birthweight babies (,2500 g) in this study (4.4%) was
less than the National (7.2%) and the Yorkshire & Humber region
average (7.8%) for 2007 (Ofﬁce for National Statistics, 2007). This
raises the possibility that women who are more likely to have low
birthweight babies were less likely to participate in this study. We
have used customized birth centile that takes into account gestational
age, maternal height, weight, ethnicity and parity and neonatal
..................................................................................................
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Table II Characteristics of women by dietary iron intake during the ﬁrst trimester reported in a 24-h dietary recall
(n5 1257).
Dietary iron intake
>14.8 mg/daya
(n 5 257)
≤14.8 mg/day
(n 5 1000)
P-value*
Dietary iron intake (mg/day), mean (95% CI) 19.6 (15.0, 31.7) 9.4 (4.5, 13.8) –
Age of mother (years), mean (95% CI) 31 (30, 31) 30 (29, 30) 0.004
Pre-pregnancy weight (kg), mean (95% CI) 66 (64, 68) 68 (67, 68) 0.1
Total energy intake (kcal), mean (95% CI) 2777 (2657, 2897) 1958 (1924, 1991) ,0.0001
(MJ), mean (95% CI) 11.6 (11.1, 12.1) 8.2 (8.1, 8.3)
Active smoker at 12 weeks (%, 95% CI) 8 (5, 12) 20 (17, 23) ,0.0001
IMD most deprived quartile (%, 95% CI) 25 (20, 31) 32 (29, 35) 0.03
Caucasian (%, 95% CI) 91 (87, 95) 94 (92, 95) 0.2
Higher education (%, 95% CI) 52 (49, 58) 35 (32, 39) ,0.0001
Vegetarian (ovo-lacto) (%, 95% CI) 13 (10, 18) 8 (6, 10) 0.004
Primigravida (%, 95% CI) 47 (41, 54) 46 (43, 49) 0.7
History of long-term illness (%, 95% CI) 9 (6, 13) 14 (12, 16) 0.04
Average alcohol consumption .0.5 units/day throughout
pregnancy (%, 95% CI)
30 (24, 36) 26 (23, 29) 0.2
Past history of miscarriage (%, 95% CI) 20 (16, 26) 25 (22, 27) 0.08
Report taking any form of daily supplements in the ﬁrst
trimester questionnaire (%, 95% CI)
87 (82, 91) 81 (78, 83) 0.01
Report taking daily iron-containing supplements in the ﬁrst
trimester questionnaire (%, 95% CI)
29 (23, 35) 23 (20, 25) 0.04
IMD, index of multiple deprivation.
*P-value using two-sample t-test for continuous variables, x2-test for categorical variables.
aReference nutrient intake (RNI) for iron for women aged 19–50 years in the UK.
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Table IV The relationship between maternal dietary iron intake during pregnancy and customized size at birth, Leeds,
UK, 2003–2006.
Customized birth centile (takes into account: maternal pre-pregnancy weight, height, parity, ethnicity, gestation and baby’s sex)
Unadjusted
change
95% CI P-value Adjusted
changea
95% CI P-value
Dietary iron intakeb 5.2 2.2, 8.2 0.001 3.1 20.2, 6.3 0.07
Dietary iron intake in participants with
vitamin C intake .50 mg/dayb
5.3 1.9, 8.6 0.002 3.9 0.4, 7.5 0.03
Non-heme iron intakeb 5.7 2.6, 8.8 ,0.0001 3.4 0.0, 8.8 0.05
Non-heme iron intake in participants with
vitamin C intake .50 mg/dayb
5.9 2.5, 9.3 0.001 4.4 0.7, 8.0 0.02
Heme iron intakec 21.2 23.3, 0.8 0.2 20.7 22.8, 1.4 0.6
Total iron intaked,b 4.3 2.4, 6.3 ,0.0001 2.5 0.4, 4.6 0.02
Total iron intaked in participants with
vitamin C intake .50 mg/dayb
4.4 2.2, 6.5 ,0.0001 3.0 0.7, 5.4 0.01
Small for gestational age (,10% centile)
Unadjusted ORe 95% CI P-value Adjusted ORa 95% CI P-value
Dietary iron intake (≤14.8 mg/day) 1.6 1.0, 2.5 0.05 1.4 0.9, 2.3 0.2
Total iron intaked (≤14.8 mg/day) 1.5 1.0, 2.1 0.04 1.2 0.8, 1.8 0.3
Preterm birth (,37-week gestation)
Unadjusted ORe 95% CI P-value Adjusted ORa 95% CI P-value
Dietary iron intake (≤14.8 mg/day) 1.1 0.7, 2.3 0.7 1.0 0.5, 2.3 0.8
Total iron intaked (≤14.8 mg/day) 1.5 0.8, 2.7 0.2 1.3 0.7, 2.5 0.4
aAdjusted for maternal age, salivary cotinine levels and alcohol intake in a multiple linear regression model, with an interaction term between iron and vitamin C intakes where the
estimates are reported in the table to be for iron intake in the group with vitamin C intake .50 mg/day.
bPercentage point change in customized centile per 10 mg/day increase in iron intake.
cPercentage point change in customized centile per 1 mg/day increase in heme iron intake.
dFrom food and supplements excluding therapeutic iron supplement takers (≥65 mg/dose).
eOdds ratio with dietary iron intake .14.8 mg/day as the reference group.
.............................................................................................................................................................................................
Table III The relationship between dietary and supplemental iron intake and maternal blood indices (Hb and MCV)
during pregnancy.
Unadjusted change 95% CI P-value Adjusted changea 95% CI P-value
Dietary iron intake≤14.8 mg/day in the ﬁrst trimester
Hb at 12 weeks (g/dl) 0.1 20.1, 0.3 0.2 0.09 20.1, 0.3 0.4
Hb at 28 weeks (g/dl) 20.1 20.3, 0.1 0.3 20.1 20.3, 0.1 0.4
MCV at 12 weeks (flb) 0.2 20.1, 1.2 0.7 0.3 20.7, 1.3 0.6
MCV at 28 weeks (fl) 20.9 22.0, 0.2 0.1 20.8 21.9, 0.3 0.2
Daily intake of iron-containing supplements in the ﬁrst trimester
Hb at 12 weeks (g/dl) 0.3 0.1, 0.4 0.005 0.2 0.05, 0.4 0.01
Hb at 28 weeks (g/dl) 0.4 0.2, 0.6 ,0.0001 0.3 0.2, 0.5 ,0.0001
MCV at 12 weeks (flb) 0.6 20.4, 1.5 0.2 0.1 20.8, 1.1 0.8
MCV at 28 weeks (fl) 1.3 0.4, 2.4 0.008 0.8 20.2, 1.8 0.1
Daily intake of iron-containing supplements in the second trimester
Hb at 28 weeks (g/dl) 0.3 0.1, 0.6 0.002 0.2 0.0, 0.5 0.05
MCV at 28 weeks (fl) 1.5 0.4, 2.8 0.01 0.7 20.05, 2.0 0.3
aAdjusted for: maternal age, ethnicity, chronic illness, Index of Multiple Deprivation score, educational attainment, parity and vegetarian diet in a linear regression model.
bFemtolitres.
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birthweight and sex. However, it does not take into account paternal
height, which has been shown to be related to birthweight (Morrison
et al., 1991; Nahum and Stanislaw, 2003).
Dietary iron intake was ascertained using 24-h dietary recall
recorded by a midwife-administered interview at around 12-week ges-
tation. This method has been validated, and found to be comparable
with other dietary assessment methods such as food frequency ques-
tionnaires and food diaries in estimating iron intake (Bingham et al.,
1997). However, 24-h recall has its limitations such as failure to
recall diet accurately and the chance of consuming non-typical diet
during the day prior to the assessment. While the study has a large
sample size and hence good probable estimates of mean daily
intake, these estimates may be more widely dispersed than in reality
due to the use of this dietary assessment method. It, therefore, may
over-estimate the proportion of mothers with extremely high or
low iron intakes—for example, the proportion with daily iron intake
less than UK LRNI (24% in our sample). However, there is evidence,
when validating 24-h recalls against other methods of dietary assess-
ment, that recall is prone to over-reporting low intakes and under-
reporting high intakes (Gersovitz et al., 1978).
The estimation of heme iron intake may have been subject to
greater error than the estimation of non-heme intake, given that it
constitutes a smaller proportion of total dietary iron. The use of sup-
plements was recorded both in the 24-h recall and the interviewer-
administered and self-reported questionnaires. The extent of agree-
ment was high between the two methods in this study for reporting
iron-containing supplements intake; however, there is potential for
measurement error using both methods. It is unlikely that women
with adverse outcomes would have reported their supplement-use
pattern or dietary intake differently to other women since it is a pro-
spective study, therefore reducing the chance of differential bias. We
decided to use the supplements reported in the recall, rather than the
questionnaire, to add to the dietary iron to derive the total iron intake
variable as they were both reported in the same recall.
Interpretation of ﬁndings
We found that non-heme (rather than heme) iron was positively
related to size at birth. This raises the possibility that the observed
relationship is due to residual confounding by an unmeasured factor
associated with both non-heme iron intake and size at birth. We,
therefore, carried out a sensitivity analysis by excluding vegetarians,
as vegetarian status may be associated with a generally healthier diet
and lifestyle. This did not change the regression estimates. It could
be that participants with a higher intake of heme iron are more
likely to have adverse birth outcomes due to lifestyle and socioeco-
nomic factors associated with high meat intake (Hulshof et al.,
2003), thus counteracting any positive effect for heme iron.
However, adjusting for educational status and IMD group did not
change the results (data not shown). Findings from the Motherwell
cohort study suggest that a diet high in low-quality meat might itself
reduce fetal growth, perhaps through stimulating a stress response
in the mother (Herrick et al., 2003).
Adjustment for total energy intake is recommended if it is a con-
founder of the relationship being examined (Willett et al., 1997).
However, we did not adjust for it here because it did not fulﬁl the deﬁ-
nition of a ‘true’ confounder. Confounding can result if total energy
intake is associated with both the exposure of interest and the main
outcome (Pearl, 2000), which is not the case in this study as total
energy intake was not associated with birthweight (data not shown).
Although effect modiﬁcation was not signiﬁcant for vitamin C, the
stronger association between iron intake and birthweight in partici-
pants whose vitamin C intake was .50 mg/day is of interest as
vitamin C is the best known enhancer of iron absorption (Pearl,
2000; Gibney et al., 2004). We used a cut-off of the pregnancy RNI
of 50 mg/day for vitamin C, but the threshold where daily vitamin
C intake starts to have an effect on iron absorption in vivo is not
exactly known.
Hb and MCV were used as proxies for iron status to assess the
extent of agreement with iron intake levels. However, there are
major limitations for the use of Hb and MCV levels as indicators of
iron status as they do not represent speciﬁc or sensitive measures
of body iron stores (Milman, 2006). We found no association
between dietary iron intake and Hb or MCV levels. This is not a sur-
prising ﬁnding as these blood indices are only affected when iron
deﬁciency is pronounced. It is difﬁcult to determine the direction of
the relationship between iron-containing supplements and Hb.
Anemic participants are more likely to take iron-containing sup-
plements. This is supported by the stronger positive relationship
between taking iron-containing supplements in the ﬁrst trimester
and Hb at 28 weeks compared with that at 12-week gestation.
Conclusion and implications for research
and practice
This study conﬁrms a positive association between total iron intake,
from food and supplements, in the ﬁrst trimester of pregnancy, and
customized birth centile. Although iron intake from food alone is
not signiﬁcantly associated with birthweight after adjustment, intake
of non-heme iron is more strongly associated with birthweight than
heme iron. Further research is needed to explore the role of
vitamin C intake in the relationship between dietary and supplemen-
tary iron intake and birth outcomes. A randomized controlled trial
of high dietary iron intake combined with vitamin C at mealtimes
during early pregnancy could provide some important insights. Public
health messages about increasing iron intake during early pregnancy
and ways to optimize iron absorption, whether from diet or sup-
plements, need to be promoted.
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